Skip to main content

Peer Review reports

From: Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study

Original Submission
7 Sep 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Oct 2021 Reviewed Reviewer Report
30 Oct 2021 Reviewed Reviewer Report - Michele Fusaroli
15 Nov 2021 Author responded Author comments - Seung In Seo
Resubmission - Version 3
15 Nov 2021 Submitted Manuscript version 3
25 Nov 2021 Author responded Author comments - Seung In Seo
Resubmission - Version 4
25 Nov 2021 Submitted Manuscript version 4
5 Dec 2021 Author responded Author comments - Seung In Seo
Resubmission - Version 5
5 Dec 2021 Submitted Manuscript version 5
13 Dec 2021 Author responded Author comments - Seung In Seo
Resubmission - Version 6
13 Dec 2021 Submitted Manuscript version 6
26 Dec 2021 Reviewed Reviewer Report - Michele Fusaroli
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
11 Jan 2022 Editorially accepted
17 Jan 2022 Article published 10.1186/s40360-022-00549-7

You can find further information about peer review here.

Back to article page